Literature DB >> 11324859

Heterogeneity of semantic and visuospatial deficits in early Alzheimer's disease.

D Caine1, J R Hodges.   

Abstract

Staging of visuospatial and semantic deficits in patients with dementia of the Alzheimer type (DAT) was examined. The authors hypothesized that semantic ability would be more impaired in these patients, reflecting predominant temporal pathology early in the disease. However, in the 1st study (n = 26), 3 patients (11.5%) had marked visual but no semantic impairment. This finding was extended in a 2nd study with a 2nd patient sample (n = 21) and more specific tasks. Two patients (9.5%) again had visual but no semantic impairment. These studies confirm that, in patients with DAT presenting with relatively focal deficits, visual deficits sometimes occur before semantic problems. The findings are discussed with regard to the cognitive demands and neuroanatomical underpinning of the tests used and point to the necessity of using cognitively specific tests to enable accurate analysis of deficits in the context of the neuroanatomical basis of impairment.

Entities:  

Mesh:

Year:  2001        PMID: 11324859

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  10 in total

1.  Visuoconstructional Impairment in Subtypes of Mild Cognitive Impairment.

Authors:  Samrah Ahmed; Laura Brennan; Joel Eppig; Catherine C Price; Melissa Lamar; Lisa Delano-Wood; Katherine J Bangen; Emily C Edmonds; Lindsey Clark; Daniel A Nation; Amy Jak; Rhoda Au; Rodney Swenson; Mark W Bondi; David J Libon
Journal:  Appl Neuropsychol Adult       Date:  2015-09-23       Impact factor: 2.248

2.  Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Authors:  Stephanie Cosentino; Janet Metcalfe; Brady Butterfield; Yaakov Stern
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

3.  Optimally-Discriminative Voxel-Based Morphometry significantly increases the ability to detect group differences in schizophrenia, mild cognitive impairment, and Alzheimer's disease.

Authors:  Tianhao Zhang; Christos Davatzikos
Journal:  Neuroimage       Date:  2013-04-28       Impact factor: 6.556

4.  Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients.

Authors:  Matthias L Schroeter; Timo Stein; Nina Maslowski; Jane Neumann
Journal:  Neuroimage       Date:  2009-05-20       Impact factor: 6.556

5.  Semantic memory impairment in dementia: A cross-cultural adaptation study.

Authors:  Avanthi Paplikar; V P Vandana; Shailaja Mekala; K J Darshini; Faheem Arshad; Gowri K Iyer; Rajamohan Kandukuri; Gollahalli Divyaraj; Feba Varghese; Subhash Kaul; Karalyn Patterson; Suvarna Alladi
Journal:  Neurol Sci       Date:  2021-05-08       Impact factor: 3.307

Review 6.  The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer's Disease.

Authors:  Eriola Hoxha; Pellegrino Lippiello; Fabio Zurlo; Ilaria Balbo; Rita Santamaria; Filippo Tempia; Maria Concetta Miniaci
Journal:  Front Aging Neurosci       Date:  2018-11-27       Impact factor: 5.750

7.  Analyzing Knowledge Retrieval Impairments Associated with Alzheimer's Disease Using Network Analyses.

Authors:  Jeffrey C Zemla; Joseph L Austerweil
Journal:  Complexity       Date:  2019-05-02       Impact factor: 2.833

8.  Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia.

Authors:  N L Graham; T Emery; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

9.  Visuospatial functions in atypical parkinsonian syndromes.

Authors:  T H Bak; D Caine; V C Hearn; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 10.  Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit.

Authors:  John P Aggleton; Agathe Pralus; Andrew J D Nelson; Michael Hornberger
Journal:  Brain       Date:  2016-04-28       Impact factor: 13.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.